Multiple Sclerosis

Mallinckrodt MNK14130050  <- click for more information

Basic Eligibility Criteria:

  • Participants 18 years or older
  • Must have been diagnosed with Relapse Remitting Multiple Sclerosis
  • Pateint planning to initiate Acthar Gel for treatment of acute MS exacerbation.

Genetech MN30035 (RRMS) <- click for more information

Basic Eligibility Criteria:

  • Male or female Age 18 to 55 years old
  • Length of disease duration of < 10 years from first symptomConfirmed diagnosis of a relapsing form of MS
  • Must be able to complete an MRI

Novartis CFTY20D2403 (RRMS) <- click for more information

Observational study for patients starting on Fingolimod

Basic Eligibility Criteria:

  • Starting Fingolimod
  • Starting another DMT or started within a maximim of 6 months prior to study entry.

 

Novartis COMB157TG2302  <- click for more information

Basic Eligibility Criteria:

  • Male or female Age ≥18 years old
  • Confirmed diagnosis of a relapsing MS(RRMS or SPMS)
  • EDSS score of 0 to 5.5

Genetech ML29972  (PPMS)<- click for more information

Basic Eligibility Criteria:

  • 18 to 55 years old
  • Diagnosis of a PPMS
  • EDSS 2.0-6.5

                                                                                      -------------------------------

If you would like further information about any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff at  203.333.1151 and we will be happy to answer any of your questions.